Coming up on Monday, Wayne Pines, E
This leads to a scenario where new therapeutic strategies for diabetes must inevitably consider not only glycemic and weight control but also the reduction of both vascular and non-vascular complications
The data shows that by facilitating substantial weight loss and improving key markers like blood sugar, blood pressure, and cholesterol, these medications offer a powerful pathway for early intervention and long-term health benefits.
GLP-1-based therapy of type 2 diabetes: GLP-1 mimetics and DPP-IV inhibitors
[DOI] [PubMed] [Google Scholar] 5.West J., Li M., Wong S., Le G.H., Teopiz K.M., Valentino K., et al
Effects can be stronger and more prolonged